New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!

ALNY Insider Trading

Insider Ownership Percentage: 1.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $10,316,756.20

Alnylam Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Alnylam Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alnylam Pharmaceuticals Share Price & Price History

Current Price: $171.41
Price Change: Price Increase of +3.16 (1.88%)
As of 12/1/2023 01:00 AM ET

This chart shows the closing price history over time for ALNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Alnylam Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/7/2023Pushkal GargCMOSell4,166$183.89$766,085.744,345View SEC Filing Icon  
8/4/2023Jeffrey V. PoultonCFOSell3,460$185.85$643,041.0015,873View SEC Filing Icon  
8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.858,511View SEC Filing Icon  
8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.4535,216View SEC Filing Icon  
4/27/2023Akshay VaishnawPresidentSell2,392$194.59$465,459.2817,890View SEC Filing Icon  
4/27/2023Jeffrey V. PoultonCFOSell977$194.59$190,114.4311,706View SEC Filing Icon  
4/27/2023Pushkal GargCMOSell1,839$194.59$357,851.016,800View SEC Filing Icon  
4/27/2023Tolga TangulerEVPSell1,476$194.59$287,214.841,801View SEC Filing Icon  
4/27/2023Yvonne GreenstreetCEOSell7,615$194.59$1,481,802.8530,332View SEC Filing Icon  
4/6/2023Indrani Lall FranchiniEVPSell3,500$210.00$735,000.00View SEC Filing Icon  
3/3/2023Pushkal GargCMOSell18,072$200.00$3,614,400.004,345View SEC Filing Icon  
2/2/2023Indrani Lall FranchiniEVPSell1,675$226.01$378,566.753,500View SEC Filing Icon  
8/5/2022Tolga TangulerEVPSell1,841$218.16$401,632.56View SEC Filing Icon  
8/3/2022Tolga TangulerEVPSell1,754$210.00$368,340.003,629View SEC Filing Icon  
7/5/2022Tolga TangulerEVPSell1,754$150.00$263,100.001,754View SEC Filing Icon  
4/1/2022Steven M. PaulDirectorSell15,000$170.69$2,560,350.001,000View SEC Filing Icon  
12/23/2021Akshay VaishnawInsiderSell2,879$190.93$549,687.47View SEC Filing Icon  
11/12/2021John MaraganoreCEOSell33,978$171.52$5,827,906.56View SEC Filing Icon  
8/13/2021John MaraganoreCEOSell33,979$199.78$6,788,324.62248,744View SEC Filing Icon  
8/6/2021Yvonne GreenstreetCOOSell53,064$199.00$10,559,736.00View SEC Filing Icon  
8/5/2021Laurie KeatingEVPSell10,000$188.95$1,889,500.0013,008View SEC Filing Icon  
7/12/2021Laurie KeatingEVPSell6,812$178.96$1,219,075.526,944View SEC Filing Icon  
6/18/2021Akshay VaishnawInsiderSell14,708$175.00$2,573,900.0024,953View SEC Filing Icon  
6/9/2021Laurie KeatingEVPSell1,734$154.00$267,036.005,132View SEC Filing Icon  
5/13/2021John MaraganoreCEOSell33,979$130.78$4,443,773.62248,744View SEC Filing Icon  
4/21/2021Akshay VaishnawInsiderSell2,732$136.95$374,147.4022,908View SEC Filing Icon  
4/19/2021Akshay VaishnawInsiderSell3,706$137.67$510,205.0222,908View SEC Filing Icon  
1/12/2021Laurie KeatingEVPSell14,941$160.20$2,393,548.202,234View SEC Filing Icon  
1/12/2021Yvonne GreenstreetCOOSell3,125$161.00$503,125.007,945View SEC Filing Icon  
12/18/2020Steven M. PaulDirectorSell15,000$140.00$2,100,000.0016,000View SEC Filing Icon  
See Full Table
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

93.98% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alnylam Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/1/2023Wellington Management Group LLP6,431,814$1.14B0.2%+6.0%5.125%Search for SEC Filing on Google Icon
11/30/2023American Century Companies Inc.442,743$78.41M0.1%+0.9%0.353%Search for SEC Filing on Google Icon
11/27/2023Banque Pictet & Cie SA25,424$4.50M0.1%-4.3%0.020%Search for SEC Filing on Google Icon
11/24/2023Deutsche Bank AG462,856$81.97M0.1%-4.9%0.369%Search for SEC Filing on Google Icon
11/24/2023EP Wealth Advisors LLC1,177$0.21M0.0%+6.4%0.001%Search for SEC Filing on Google Icon
11/22/2023Graham Capital Management L.P.1,427$0.25M0.0%-19.3%0.001%Search for SEC Filing on Google Icon
11/21/2023Comerica Bank13,426$2.38M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/16/2023Creative Planning4,121$0.73M0.0%-16.8%0.003%Search for SEC Filing on Google Icon
11/16/2023Orion Capital Management LLC3,675$0.65M0.4%-7.5%0.003%Search for SEC Filing on Google Icon
11/16/2023Tudor Investment Corp Et Al60,004$10.63M0.1%+595.5%0.048%Search for SEC Filing on Google Icon
11/16/2023Public Employees Retirement System of Ohio54,670$9.68M0.0%-9.3%0.044%Search for SEC Filing on Google Icon
11/15/2023iA Global Asset Management Inc.4,174$0.74M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/15/2023The Manufacturers Life Insurance Company 355,863$63.02M0.0%+8.9%0.284%Search for SEC Filing on Google Icon
11/15/2023Royal London Asset Management Ltd.306,595$54.30M0.2%+86.7%0.244%Search for SEC Filing on Google Icon
11/15/2023Rock Springs Capital Management LP279,500$49.50M1.3%-19.0%0.223%Search for SEC Filing on Google Icon
11/15/2023Schroder Investment Management Group7,655$1.36M0.0%-6.7%0.006%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.28,960$5.13M1.0%-2.9%0.023%Search for SEC Filing on Google Icon
11/15/2023Legal & General Group Plc794,671$140.74M0.0%-0.5%0.633%Search for SEC Filing on Google Icon
11/15/2023Ameriprise Financial Inc.706,200$125.07M0.0%+12.9%0.563%Search for SEC Filing on Google Icon
11/15/2023Advisors Asset Management Inc.1,292$0.23M0.0%+40.9%0.001%Search for SEC Filing on Google Icon
11/15/2023AQR Capital Management LLC9,460$1.66M0.0%+65.0%0.008%Search for SEC Filing on Google Icon
11/14/2023Lazard Asset Management LLC15,831$2.80M0.0%+1,585.9%0.013%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC42,107$7.46M0.1%+1,607.5%0.034%Search for SEC Filing on Google Icon
11/14/2023Gotham Asset Management LLC3,082$0.55M0.0%-20.1%0.002%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.1,338$0.24M0.1%-53.7%0.001%Search for SEC Filing on Google Icon
11/14/2023Karani Asset Management LLC11,555$2.05M2.9%-24.2%0.009%Search for SEC Filing on Google Icon
11/14/2023Teza Capital Management LLC1,318$0.23M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/14/2023California State Teachers Retirement System190,231$33.69M0.1%-4.2%0.152%Search for SEC Filing on Google Icon
11/14/2023Toronto Dominion Bank55,262$9.79M0.0%+79.1%0.044%Search for SEC Filing on Google Icon
11/14/2023Bank of Nova Scotia2,948$0.52M0.0%+18.3%0.002%Search for SEC Filing on Google Icon
11/14/2023Tower Research Capital LLC TRC 5,090$0.90M0.0%-46.8%0.004%Search for SEC Filing on Google Icon
11/14/2023Qube Research & Technologies Ltd1,000$0.18M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/14/2023Treasurer of the State of North Carolina85,957$15.22M0.1%-1.1%0.068%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP11,021$1.95M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/14/2023MQS Management LLC1,225$0.22M0.1%N/A0.001%Search for SEC Filing on Google Icon
11/14/2023O Shaughnessy Asset Management LLC1,594$0.28M0.0%+19.3%0.001%Search for SEC Filing on Google Icon
11/14/2023OMERS ADMINISTRATION Corp4,000$0.71M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC7,257$1.29M0.1%-6.1%0.006%Search for SEC Filing on Google Icon
11/13/2023Eagle Asset Management Inc.262,680$46.52M0.3%+1.4%0.209%Search for SEC Filing on Google Icon
11/13/2023Meiji Yasuda Asset Management Co Ltd.1,380$0.24M0.0%+13.1%0.001%Search for SEC Filing on Google Icon
11/13/2023Northern Trust Corp797,700$141.27M0.0%+3.3%0.636%Search for SEC Filing on Google Icon
11/13/2023Stifel Financial Corp8,069$1.43M0.0%-13.4%0.006%Search for SEC Filing on Google Icon
11/13/2023Mariner LLC14,181$2.51M0.0%-20.5%0.011%Search for SEC Filing on Google Icon
11/13/2023LPL Financial LLC15,770$2.79M0.0%+6.0%0.013%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC904$0.16M0.0%+52.4%0.001%Search for SEC Filing on Google Icon
11/13/2023Hsbc Holdings PLC35,185$6.23M0.0%+14.7%0.028%Search for SEC Filing on Google Icon
11/13/2023Bison Wealth LLC2,553$0.45M0.1%-45.8%0.002%Search for SEC Filing on Google Icon
11/13/2023CI Investments Inc.2,648$0.47M0.0%-11.3%0.002%Search for SEC Filing on Google Icon
11/13/2023Envestnet Asset Management Inc.24,570$4.35M0.0%+30.4%0.020%Search for SEC Filing on Google Icon
11/13/2023Nordea Investment Management AB8,690$1.53M0.0%+3.1%0.007%Search for SEC Filing on Google Icon
11/13/2023Envestnet Portfolio Solutions Inc.1,279$0.23M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/13/2023Korea Investment CORP33,061$5.86M0.0%-15.0%0.026%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC44,168$7.82M0.0%+1.4%0.035%Search for SEC Filing on Google Icon
11/13/2023Baillie Gifford & Co.8,163,139$1.45B1.3%-2.7%6.505%Search for SEC Filing on Google Icon
11/13/2023Prudential PLC4,878$0.86M0.0%-13.5%0.004%Search for SEC Filing on Google Icon
11/13/2023ANTIPODES PARTNERS Ltd111,834$19.46M0.6%+199,603.6%0.089%Search for SEC Filing on Google Icon
11/13/2023DekaBank Deutsche Girozentrale143,100$24.85M0.1%-10.8%0.114%Search for SEC Filing on Google Icon
11/13/2023E Fund Management Co. Ltd.2,271$0.40M0.0%-3.0%0.002%Search for SEC Filing on Google Icon
11/9/2023Loomis Sayles & Co. L P625,401$110.76M0.2%-3.1%0.498%Search for SEC Filing on Google Icon
11/9/2023Rhumbline Advisers172,071$30.47M0.0%-1.9%0.137%Search for SEC Filing on Google Icon
11/9/2023Rhenman & Partners Asset Management AB119,000$22.90M1.8%+164.4%0.095%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG462,856$81.97M0.0%-4.9%0.369%Search for SEC Filing on Google Icon
11/9/2023Greenleaf Trust2,533$0.45M0.0%-3.4%0.002%Search for SEC Filing on Google Icon
11/9/2023Skandinaviska Enskilda Banken AB publ 93,225$16.50M0.1%+0.4%0.074%Search for SEC Filing on Google Icon
11/9/2023Andra AP fonden34,500$6.11M0.4%-14.8%0.027%Search for SEC Filing on Google Icon
11/9/2023Liontrust Investment Partners LLP967$0.17M0.0%-91.4%0.001%Search for SEC Filing on Google Icon
11/9/2023Headlands Technologies LLC1,146$0.20M0.1%-57.0%0.001%Search for SEC Filing on Google Icon
11/9/2023Mitsubishi UFJ Trust & Banking Corp386,672$68.48M0.2%-1.7%0.308%Search for SEC Filing on Google Icon
11/9/2023Canada Pension Plan Investment Board151,298$26.80M0.0%-9.7%0.121%Search for SEC Filing on Google Icon
11/8/2023State of New Jersey Common Pension Fund D71,585$12.68M0.0%-3.0%0.057%Search for SEC Filing on Google Icon
11/8/2023State Board of Administration of Florida Retirement System131,210$23.24M0.1%-3.9%0.105%Search for SEC Filing on Google Icon
11/8/2023HighTower Advisors LLC124,439$22.06M0.0%-1.1%0.100%Search for SEC Filing on Google Icon
11/8/2023Pathstone Family Office LLC1,240$0.22M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/8/2023Vanguard Personalized Indexing Management LLC5,735$1.02M0.0%-9.8%0.005%Search for SEC Filing on Google Icon
11/8/2023Van ECK Associates Corp71,086$12.59M0.0%-8.8%0.057%Search for SEC Filing on Google Icon
11/8/2023Shell Asset Management Co.4,832$0.86M0.0%-1.6%0.004%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.418,980$74.20M0.0%+0.7%0.335%Search for SEC Filing on Google Icon
11/8/2023Sequoia Financial Advisors LLC2,803$0.50M0.0%-5.0%0.002%Search for SEC Filing on Google Icon
11/8/2023Parnassus Investments LLC38,748$6.86M0.0%N/A0.031%Search for SEC Filing on Google Icon
11/8/2023Massachusetts Financial Services Co. MA688,228$121.89M0.0%+2.4%0.551%Search for SEC Filing on Google Icon
11/8/2023Swiss National Bank400,600$70.95M0.1%-10.5%0.320%Search for SEC Filing on Google Icon
11/8/2023Banque Cantonale Vaudoise2,058$0.37M0.0%-58.0%0.002%Search for SEC Filing on Google Icon
11/8/2023Amalgamated Bank12,746$2.26M0.0%-3.0%0.010%Search for SEC Filing on Google Icon
11/8/2023Moody Aldrich Partners LLC2,283$0.40M0.1%N/A0.002%Search for SEC Filing on Google Icon
11/8/2023New York Life Investment Management LLC2,226$0.39M0.0%-7.7%0.002%Search for SEC Filing on Google Icon
11/8/2023Oppenheimer & Co. Inc.4,519$0.80M0.0%+2.1%0.004%Search for SEC Filing on Google Icon
11/7/2023Great Lakes Advisors LLC1,445$0.26M0.0%-4.8%0.001%Search for SEC Filing on Google Icon
11/7/2023Virtus ETF Advisers LLC1,533$0.27M0.2%-11.4%0.001%Search for SEC Filing on Google Icon
11/7/2023Impax Asset Management Group plc2,903$0.51M0.0%-5.4%0.002%Search for SEC Filing on Google Icon
11/7/2023Clearstead Advisors LLC4,518$0.80M0.0%+197.6%0.004%Search for SEC Filing on Google Icon
11/7/2023Metis Global Partners LLC4,288$0.76M0.0%+8.7%0.003%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC162,195$28.73M0.0%-22.8%0.130%Search for SEC Filing on Google Icon
11/7/2023Arizona State Retirement System33,973$6.02M0.1%+0.5%0.027%Search for SEC Filing on Google Icon
11/7/2023abrdn plc23,025$4.08M0.0%-2.4%0.018%Search for SEC Filing on Google Icon
11/7/2023Mitsubishi UFJ Kokusai Asset Management Co. Ltd.52,479$9.29M0.0%+12.9%0.042%Search for SEC Filing on Google Icon
11/7/2023Segantii Capital Management Ltd19,250$3.41M0.1%-33.2%0.015%Search for SEC Filing on Google Icon
11/6/2023Privium Fund Management B.V.20,023$3.55M1.1%N/A0.016%Search for SEC Filing on Google Icon
11/6/2023Illinois Municipal Retirement Fund15,644$2.77M0.1%N/A0.013%Search for SEC Filing on Google Icon
11/6/2023Assenagon Asset Management S.A.6,730$1.19M0.0%-92.6%0.005%Search for SEC Filing on Google Icon
11/6/2023Sector Gamma AS52,968$9.38M2.4%+88.7%0.042%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; ALN-AAT02 for the treatment of AAT deficiency-associated liver disease; ALN-HBV02 to treat chronic HBV infection; Zilebesiran to treat hypertension; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia and rare bleeding disorders, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1 and recurrent renal stones, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Read More on Alnylam Pharmaceuticals

Today's Range

Now: $171.41
Low: $166.02
High: $171.42

50 Day Range

MA: $166.11
Low: $151.41
High: $178.96

52 Week Range

Now: $171.41
Low: $148.10
High: $242.97

Volume

366,015 shs

Average Volume

675,577 shs

Market Capitalization

$21.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top insider investors include:
  1. Yvonne Greenstreet (CEO)
  2. Akshay Vaishnaw (President)
  3. Jeffrey V Poulton (CFO)
  4. Pushkal Garg (CMO)
  5. Tolga Tanguler (EVP)
  6. Indrani Lall Franchini (EVP)
  7. Steven M Paul (Director)
  8. Akshay Vaishnaw (Insider)
Learn More about top insider investors at Alnylam Pharmaceuticals.

Who are the major institutional investors of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top institutional shareholders include:
  1. Baillie Gifford & Co. — 6.51%
  2. Wellington Management Group LLP — 5.13%
  3. Northern Trust Corp — 0.64%
  4. Legal & General Group Plc — 0.63%
  5. Ameriprise Financial Inc. — 0.56%
  6. Massachusetts Financial Services Co. MA — 0.55%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.

Which major investors are selling Alnylam Pharmaceuticals stock?

In the last quarter, ALNY stock was sold by these institutional investors:
  1. Baillie Gifford & Co.
  2. Assenagon Asset Management S.A.
  3. Rock Springs Capital Management LP
  4. Barclays PLC
  5. Swiss National Bank
  6. Deutsche Bank AG
  7. Deutsche Bank AG
  8. Loomis Sayles & Co. L P
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
  1. Yvonne Greenstreet (CEO)
  2. Akshay Vaishnaw (President)
  3. Jeffrey V Poulton (CFO)
  4. Pushkal Garg (CMO)
  5. Tolga Tanguler (EVP)
  6. Indrani Lall Franchini (EVP)
Learn More investors selling Alnylam Pharmaceuticals stock.

Which major investors are buying Alnylam Pharmaceuticals stock?

In the previous quarter, ALNY stock was acquired by institutional investors including:
  1. Wellington Management Group LLP
  2. Royal London Asset Management Ltd.
  3. TD Asset Management Inc
  4. ANTIPODES PARTNERS Ltd
  5. Ameriprise Financial Inc.
  6. Rhenman & Partners Asset Management AB
  7. U.S. Capital Wealth Advisors LLC
  8. Tudor Investment Corp Et Al